Effects of xylazine and dexmedetomidine on equine articular chondrocytes in vitro.

The research article explores the effects of two drugs, xylazine and dexmedetomidine, on horse chondrocytes in laboratory conditions. It discovers that these drugs can reduce cell viability and cause loss of membrane integrity, raising concerns about their potential chondrotoxicity.

Objective and Methods

• The primary aim was to investigate the impact of xylazine and dexmedetomidine on equine chondrocytes in vitro.
• Chondrocytes, the only cells in cartilage, were extracted from the joint cartilage of five male horses.
• The cells were exposed to varying concentrations of each drug for different durations, ranging between 15 and 60 minutes.
• The WST-8 assay was used to evaluate cell viability, a test that indicates how many cells remained alive after the treatment.

Additional Evaluations

• Following initial tests, the cells were also treated with certain concentrations of xylazine or dexmedetomidine for 15 minutes.
• The neutral red uptake test was used to further measure cell viability.
• Cell membrane integrity was assessed using two methods: measuring the release of lactate dehydrogenase enzyme and using fluorescence microscopy with dyes Hoechst 33342 and propidium iodide.
• They also examined apoptosis or cell death using flow cytometry and observing cell morphology.

Results

• Both drugs were found to reduce cell viability in a dose-dependent manner, i.e., the higher the concentration, the larger the decrease in cell survival.
• Xylazine significantly decreased cell viability at almost all tested concentrations, while dexmedetomidine showed similar effects only at the highest concentrations.
• The highest tested concentrations of both drugs resulted in a loss of membrane integrity, a critical aspect of cell survival.
• Microscopy and cytometry analysis indicated late apoptosis in cells subjected to xylazine, whereas dexmedetomidine-treated cells showed signs of both late apoptosis and necrosis (cell death).

Conclusions

• In light of these findings, the researchers suggest careful administration of these drugs, especially at high concentrations. This is due to their potential chondrotoxic impact, which could harm chondrocytes.
• This study contributes valuable insights into the potential risks associated with using these drugs in equine veterinary practice, particularly when administered directly into joints.